NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Isto Biologics

Isto Biologics

Private
Hopkinton, MassachusettsHealthcare & Life Scienceshttps://istobiologics.com/

Last Round

Buyout/LBO

Sep 17, 2025

Est. Valuation

$1B

Total Funding Raised

$37.8M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Isto Biologics is a biotechnology company that manufactures orthobiologic medical devices, including autologous concentration systems, allografts, and biosynthetic bone grafts, for use in spine, orthopedics, and sports medicine.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Advanced Materials, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

orthobiologicsbone graftautologous therapyplatelet-rich plasmaPRPregenerative medicinesurgical biologicsallograftbone graft substitutespine surgerymedical devicemedtechconcentrated bone marrow aspiratecBMAspinal fusionsports medicineautologous concentration system

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Isto Biologics Comparables

Compare Isto Biologics with similar companies based on industry and business-model similarity.

Isto Biologics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Royal Biologics
79%
Xtant Medical Holdings
79%
VIVEX Biologics
78%

Isto Biologics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Buyout/LBOSep 17, 2025
M&AOct 25, 2023
Buyout/LBOJun 3, 2016
DebtMar 18, 2014
Growth EquityOct 25, 2007
Series E
Aug 1, 2007

Isto Biologics Investors

Notable investors and investment history

Isto Biologics investors
InvestorRounds
DW Healthcare PartnersGrowth Equity
EQT Life SciencesSeries E, Series D
Mid-America Transplant ServicesSeries E, Series D
Thompson Street Capital PartnersBuyout/LBO, M&A
Keensight CapitalBuyout/LBO
Alafi CapitalSeries E, Series D
Ascension VenturesSeries E

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 17, 2025

    $1.0B round led by Keensight Capital

  • Oct 25, 2023

    Funded by Thompson Street Capital Partners.

Isto Biologics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Isto Biologics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Isto Biologics's valuation, stock price, and market status.

Firmographic Details

HeadquartersHopkinton, Massachusetts
Employee Range13
Year Founded1997
Last FundingSep 17, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.